Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study

Diabetes Technology and Therapeutics

Volumn 15, Issue 6, 2013, Pages 466-474

  Cleary, Patricia A ^a   Braffett, Barbara H ^a   Orchard, Trevor ^b   Lyons, Timothy J ^c   Maynard, John ^d   Cowie, Catherine ^e   Gubitosi Klug, Rose A ^f   Way, Jeff ^d   Anderson, Karen ^a   Barnie, Annette ^g   Villavicencio, Stephan ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF OKLAHOMA   (United States)

^d VeraLight Inc   (United States)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^f UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; CUTANEOUS PARAMETERS; DIABETES CONTROL; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; DRUG USE; ELBOW; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOREARM; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY INJURY; LATITUDE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SELF REPORT; SKIN COLOR; SKIN INTRINSIC FLUORESCENCE; SMOKING; SPECTROFLUOROMETRY; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGING; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; FOREARM; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PHENOTYPE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SKIN; SMOKING; SPECTROMETRY, FLUORESCENCE;

EID: 84878601837     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0316     Document Type: Article

References (34)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-986.
2. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 1999;22:99-111.
3. Monnier VM, Bautista O, Kenny D, Sell DR, Fogarty J, Dahms W, Cleary PA, Lachin J, Genuth S: Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes 1999;48:870-880. (Pubitemid 29153089)
4. Genuth S, Sun W, Cleary P, Sell DR, Dahms W, Malone J, Sivitz W, Monnier VM; DCCT Skin Collagen Ancillary Study Group: Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications participants with type 1 diabetes. Diabetes 2005;54:3103-3111. (Pubitemid 43334362)
5. Hull E, Ediger M, Unione A, Deemer E, Stroman M, Baynes J: Noninvasive, optical detection of diabetes: model studies with porcine skin. Optics Express 2004;12:4496-4510.
6. Meerwaldt R, Graaf R, Oomen PH, Links TP, Jagger JJ, Alderson NL, Thorpe SR, Baynes JW, Gans RO, Smit AJ: Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004;47:1324- 1330. (Pubitemid 39093330)
7. Beisswenger PJ, Howell S, Mackenzie T, Corstjens H, Muizzuddin N, Matsui MS: Two fluorescent wavelengths, 440ex/520em nm and 370ex/440em nm, reflect advanced glycation and oxidation end products in human skin without diabetes. Diabetes Technol Ther 2012;14:285-292.
8. Thorpe S, Lyons T, Baynes J: Glycation and glycoxidation in diabetic vascular disease. In: Keaney JF, ed. Oxidative Stress and Vascular Disease. Norwell, MA: Kluwer, 2000:259-285.
9. Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54:1615-1625. (Pubitemid 40770750)
10. Yu Y, Thorpe SR, Jenkins AJ, Shaw JN, Sochaski MA, McGee D, Aston CE, Orchard TJ, Silvers N, Peng YG, McKnight JA, Baynes JW, Lyons TJ; DCCT/EDIC Research Group: Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes. Diabetologia 2006;49:2488-2498. (Pubitemid 44359112)
11. Ahmed N: Advanced glycation endproducts - role in pathology of diabetic complications. Diabetes Res Clin Pract 2005;67:3-21. (Pubitemid 40037725)
12. Conway BN, Aroda VR, Maynard JD, Matter N, Fernandez S, Ratner RE, Orchard TJ: Skin intrinsic fluorescence correlates with autonomic and distal symmetrical polyneuropathy in individuals with type 1 diabetes. Diabetes Care 2011;34:1000-1005.
13. Sell DR, Monnier VM: Molecular basis of arterial stiffening: role of glycation - a mini-review. Gerontology 2012;58: 227-237.
14. Dyer DG, Dunn JA, Thorpe SR, Bailie KE, Lyons TJ, McCance DR, Baynes JW: Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 1993;91:2463-2469. (Pubitemid 23182497)
15. Meerwaldt R, Hartog JW, Graaf R, Huisman RJ, Links TP, den Hollander NC, Thorpe SR, Baynes JW, Navis G, Gans RO, Smit AJ: Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol 2005;16:3687-3693. (Pubitemid 46211290)
16. Monnier VM, Vishwanath V, Frank KE, Elmets CA, Dauchot P, Kohn RR: Relation between complications of type 1 diabetes mellitus and collagen-linked fluorescence. N Engl J Med 1986;314:403-408. (Pubitemid 16161885)
17. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group. Diabetes 1986;35: 530-545.
18. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med 2000;342:381-389.
19. Conway B, Edmundowicz D, Matter N, Maynard J, Orchard T: Skin fluorescence correlates strongly with coronary artery calcification severity in type 1 diabetes. Diabetes Technol Ther 2010;12:339-345.
20. Steffes M, Cleary P, Goldstein D, Little R, Wiedmeyer HM, Rohlfing C, England J, Bucksa J, Nowicki M: Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study. Clin Chem 2005;51: 753-758. (Pubitemid 40463927)
21. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF3, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J: A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612.
22. DCCT/EDIC Research Group, de Boer IH, Sun W, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Zinman B: Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med 2011;365:2366-2376.
23. Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR: 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 2011;57:63-69.
24. Tarcin O, Yavuz DG, Ozben B, Telli A, Ogunc AV, Yuksel M, Toprak A, Yazici D, Sancak S, Deyneli O, Akalin S: Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 2009;94:4023-4030.
25. Yiu YF, Chan YH, Yiu KH, Siu CW, Li SW, Wong LY, Lee SW, Tam S, Wong EW, Cheung BM, Tse HF: Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes. J Clin Endocrinol Metab 2011; 96:E830-E835.
26. Danescu LG, Levy S, Levy L: Vitamin D and diabetes mellitus. Endocrine 2009;35:11-17.
27. Mooy JM, Grootenhuis PA, de Vries H, Kostense PJ, Popp- Snijders C, Bouter LM, Heine RJ: Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn study. Diabetologia 1996; 39:298-305. (Pubitemid 26066801)
28. Na R, Stender IM, Henriksen M, Wulf HC: Autofluorescence of human skin is age-related after correction for skin pigmentation and redness. J Invest Dermatol 2001;116:536-540. (Pubitemid 32299842)
29. Maynard J, Matter N: Non-invasive skin fluorescence age trends in subjects with normal health are gender dependent [abstract]. Diabetologia 2011;54(Suppl 1):S147.
30. Gerrits EG, Lutgers HL, Kleefstra N, Graaf R, Groenier KH, Smit AJ, Gans RO, Bilo HJ: Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications. Diabetes Care 2008;31: 517-521.
31. Chabroux S, Canoui-Poitrine F, Reffet S, Mills-Joncour G, Morelon E, Colin C, Thivolet C: Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy. Diabetes Metab 2010;36:152-157.
32. Jee SH, Foong AW, Hur NW, Samet JW: Smoking and risk for diabetes incidence and mortality in Korean men and women. Diabetes Care 2010;33:2567-2572.
33. Dickerson TJ, Janda KD: A previously undescribed chemical link between smoking and metabolic disease. Proc Natl Acad Sci U S A 2002;99:15084-15088. (Pubitemid 35334613)
34. Heikal AA: Intracellular coenzymes as natural biomarkers for metabolic activities and mitochondrial anomalies. Biomark Med 2010;4:241-263.